Cyclopharm defers US guidance despite $17.1M revenue
Cyclopharm (ASX:CYC) defers short-term US installation guidance due to delayed clinical guidelines, despite reporting preliminary global revenue of $17.1 million.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Cyclopharm (ASX:CYC) defers short-term US installation guidance due to delayed clinical guidelines, despite reporting preliminary global revenue of $17.1 million.
Osteopore (ASX:OSX) has completed the development project for its intra-operative external ventricular drain guide.
Algorae Pharmaceuticals (ASX:1AI) has secured a three-year public hospital supply contract with NSW Health.
Enlitic (ASX:ENL) signed a three-year Ensight subscription contract worth $359,000 with Lumus Imaging to enter the Australian market.
Inoviq (ASX:IIQ) alters its EXO-OC ovarian cancer test development pathway after sample degradation in a 1,200-sample study renders them unsuitable for evaluation.
Biome Australia (ASX:BIO) has reported a 30% increase in preliminary annual sales revenue to $23.9 million for FY26.
Imugene (ASX:IMU) announced that the first patient in its azer-cel Phase 1b trial cohort achieved a complete response.
Recce Pharmaceuticals (ASX:RCE) has secured firm commitments to raise $4 million through a new institutional share placement.
Visionflex (ASX:VFX) has secured an approximately $0.8 million contract with NSW Health to supply clinical hardware.
4DMedical (ASX:4DX) has secured Australian TGA regulatory approval for its CT:VQ non-contrast lung imaging software.
Echo IQ (ASX:EIQ) executed a binding agreement for a proposed investment of up to $20 million and a partnership with Pro Medicus (ASX:PME).
AFT Pharmaceuticals (ASX:AFP) secured US FDA approval to launch a Phase 3 trial targeting a US$7.41 billion market.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade